Legal and Scientific Controversy Surrounding Tylenol and Autism Claims

Recent comments by President Donald Trump linking the use of Tylenol (acetaminophen) during pregnancy to an increased risk of autism have reignited legal battles against Kenvue, the drug's manufacturer. These statements have led to a surge in inquiries from potential plaintiffs, as well as renewed scrutiny of existing lawsuits alleging that prenatal exposure to acetaminophen may cause autism and ADHD.

NPR

The controversy surrounding acetaminophen's safety during pregnancy has been ongoing, with various studies suggesting a potential association with neurodevelopmental disorders. However, a significant ruling in December 2023 by U.S. District Judge Denise Cote excluded expert testimony from plaintiffs, leading to the dismissal of lawsuits against Kenvue. The judge criticized the scientific basis of the claims, stating that the evidence did not sufficiently establish causation.

Appeals Court Urged To Reinstate Tylenol Lawsuits Over Autism, ADHD Risks

• Donald Trump: Former President of the United States, whose recent comments have influenced public perception and legal proceedings regarding Tylenol.

NPR

• Kenvue: The current manufacturer of Tylenol, which spun off from Johnson & Johnson in 2023.

Tylenol, FDA Knew About Autism Risk For Years, Newly Surfaced Emails Show

• Ashley Keller: Attorney representing plaintiffs in the lawsuits against Kenvue, who has noted an influx of inquiries following Trump's statements.

NPR

• Dr. Andrea Baccarelli: A scientist whose work was cited by the Trump administration, potentially bolstering the plaintiffs' case.

NPR

Kenvue has issued statements rejecting any claims that acetaminophen causes autism, asserting that decades of research demonstrate its safety when used as directed. The FDA has announced plans to update safety labels for acetaminophen, acknowledging studies that suggest an association with autism but clarifying that causation has not been established. Critics, including legal experts, have expressed concern over the implications of Trump's statements, arguing that they may mislead the public and complicate the legal landscape without new scientific evidence.

NPR

Critics argue that Trump's comments could exacerbate stigma against mothers and misrepresent the scientific consensus. Experts like Dr. Aaron Kesselheim have stated that the existing research has not fundamentally changed, and the legal challenges remain difficult to prove. Sonia Suter, a law and medicine professor, emphasized the dangers of making unsupported claims about public health.

NPR

While some studies suggest a slight increase in autism diagnoses among children exposed to acetaminophen in utero, larger studies utilizing sibling comparisons have found no significant differences in autism rates between exposed and unexposed siblings. This discrepancy highlights the complexity of establishing a causal link and raises questions about the validity of earlier findings.

Genetic Literacy Project

• “Taking Tylenol is not good. All right. I’ll say it. It’s not good. For this reason, they are strongly recommending that women limit Tylenol use during pregnancy unless medically necessary. That’s, for instance, in cases of extremely high fever, that you feel you can’t tough it out.” — Donald Trump, Former President of the United States

New York Times

• “I think there's something very dangerous about the president using his power to make statements that are not supported in the science,” — Sonia Suter, Professor of Law and Medicine

NPR

• “The onus to warn does not arise when there is a clear cause and effect,” — Dr. David Healy, Psychiatrist and Expert Witness

Tylenol, FDA Knew About Autism Risk For Years, Newly Surfaced Emails Show

Oral arguments for the appeal of the dismissed lawsuits are scheduled to begin on October 6, 2025. The outcome may hinge on the interpretation of scientific evidence and the impact of recent governmental statements on public perception and legal proceedings.

NPR